These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 6676671)

  • 1. [Immunological evaluation of splenectomy in tumor-bearing mice].
    Yamagishi H; Naito K; Maeda Y; Kurioka H; Kobayashi M; Fujimori C; Iguchi K; Tanaka T; Hashimoto I
    Nihon Geka Gakkai Zasshi; 1983 Sep; 84(9):987-91. PubMed ID: 6676671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of splenectomy upon tumor growth: characterization of splenic tumor-enhancing cells in vivo.
    Yamagishi H; Pellis NR; Kahan BD
    Surgery; 1980 Jun; 87(6):655-61. PubMed ID: 6445603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Role of the spleen in OK-432 immunotherapy and characterization of effector cells].
    Yamagishi H; Naito K; Maeda Y; Kobayashi M; Kurioka H; Fujimori C; Tanaka T; Hashimoto I
    Gan To Kagaku Ryoho; 1983 Jul; 10(7):1670-8. PubMed ID: 6870309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Experimental study on immunological effect of splenectomy on tumor-bearers].
    Tanemura H; Saji S; Takekoshi T; Yamamoto S; Oshita H; Sakata K
    Nihon Geka Gakkai Zasshi; 1983 Sep; 84(9):982-6. PubMed ID: 6676670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of in vivo generation of cytotoxic effector cells against tumor in tumor-bearing mice.
    Fuyama S; Yamamoto H; Fujii Y; Arai S
    Cancer Res; 1986 Nov; 46(11):5548-52. PubMed ID: 2428480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of effector cells mediating antitumor activity in spleen cells of tumor-bearing mice.
    Fuyama S; Yamamoto H; Arai S
    Cancer Res; 1985 Sep; 45(9):4103-8. PubMed ID: 3875404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of the spleen in tumor bearing host: II. The influence of splenectomy in mice.
    Yamagishi H; Oka T; Hashimoto I; Pellis NR; Kahan BD
    Jpn J Surg; 1984 Jan; 14(1):72-7. PubMed ID: 6737803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Changes in immunological function of spleen in rats implanted with N-methyl-N'-nitro-N-nitrosoguanidine-induced gastric cancer].
    Matsumoto K
    Nihon Geka Gakkai Zasshi; 1994 Jul; 95(7):448-57. PubMed ID: 8072484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytostatic effect of spleen cells of tumor-bearing mice on syngenetic tumor cells.
    Lespinats G; Poupon MF
    Cancer Res; 1977 Jun; 37(6):1727-32. PubMed ID: 870185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of T-cells in the mechanism of reactivity of the microplate leukocyte adherence inhibition assay.
    Raina S; Russo AJ; Jenkins D; Goldrosen MH
    Cancer Res; 1981 Oct; 41(10):3950-5. PubMed ID: 6456811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro reactivity of splenic lymphocytes from normal and UV-irradiated mice against syngeneic UV-induced tumors.
    Fortner GW; Kripke ML
    J Immunol; 1977 Apr; 118(4):1483-7. PubMed ID: 66296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The effect of the spleen on tumor growth in mouse lines with various spleen sizes].
    von Wallenberg H; Mainusch P; Meyer J; Hammer C
    Chir Forum Exp Klin Forsch; 1979; ():169-73. PubMed ID: 313319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro reeducated T helper cells from sarcoma-bearing mice inhibit sarcoma growth in vivo.
    Forni G; Giovarelli M
    J Immunol; 1984 Jan; 132(1):527-33. PubMed ID: 6228583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Nocardia rubra cell wall skeleton on T-cell-mediated cytotoxicity in mice bearing syngeneic sarcoma.
    Kawase I; Uemiya M; Yoshimoto T; Ogura T; Hirao F; Yamamura Y
    Cancer Res; 1981 Feb; 41(2):660-6. PubMed ID: 6969630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The mechanism of tumor growth inhibition by tumor-specific Lyt-1+2-T cells. I. Antitumor effect of Lyt-1+2-T cells depends on the existence of adherent cells.
    Fujiwara H; Takai Y; Sakamoto K; Hamaoka T
    J Immunol; 1985 Sep; 135(3):2187-91. PubMed ID: 3874911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The immunological basis of tumor rejection: the absolute dependence of the effector arm on sensitized T cells after chemoimmunotherapy of a murine sarcoma.
    Evans R; Duffy T
    J Immunol; 1985 Jun; 134(6):4255-60. PubMed ID: 3872913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Some characteristics of the cyclophosphamide-induced immunopotentiating cells in the spleen of mice bearing a large MOPC-315 tumor.
    Mokyr MB; Ye QW
    Cancer Res; 1985 Oct; 45(10):4932-9. PubMed ID: 4027979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo generation of tumor-specific cytotoxic T-cells in the regional lymph node: effect of subcutaneous inoculation of mls-disparate spleen cells around implanted tumors in mice.
    Higasa M; Yamada K; Takagaki Y; Aoki M; Shinka S; Dohi Y
    Cancer Res; 1986 Oct; 46(10):4991-4. PubMed ID: 3489518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Subcutaneous injection of spleen cells from mice bearing large methylcholanthrene-induced sarcoma enhances subcutaneous tumors and artificial pulmonary metastases].
    Tsuchiya K; Yamagishi H; Hamada H; Komichi H; Oka T; Tanaka T; Inaba S
    Nihon Geka Gakkai Zasshi; 1987 Jul; 88(7):826-31. PubMed ID: 2444868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor-specific immune responsiveness of the tumor-bearing host.
    Burk MW; Yu S; McKhann CF
    Isr J Med Sci; 1976; 12(4-5):360-8. PubMed ID: 939694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.